These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Evidence of elevated colorectal cancer and adenoma rates for regional National Bowel Cancer Screening Program participants. Versace VL; Forsyth AD; Vaughan R; Morrice MG; Morphett BJ Aust J Rural Health; 2018 Feb; 26(1):63-64. PubMed ID: 28776860 [No Abstract] [Full Text] [Related]
28. Colorectal Cancer Screening Decisions in the Opportunistic Setting. Han A; Maratt J; Kahi C Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):413-422. PubMed ID: 32439079 [TBL] [Abstract][Full Text] [Related]
29. Colonoscopy and Sigmoidoscopy Use among the Average-Risk Population for Colorectal Cancer: A Systematic Review and Trend Analysis. Cardoso R; Niedermaier T; Chen C; Hoffmeister M; Brenner H Cancer Prev Res (Phila); 2019 Sep; 12(9):617-630. PubMed ID: 31289028 [TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States). Purdue MP; Mink PJ; Hartge P; Huang WY; Buys S; Hayes RB Cancer Causes Control; 2005 Oct; 16(8):965-73. PubMed ID: 16132805 [TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer screening reduces incidence, mortality and morbidity. Jideh B; Bourke MJ Med J Aust; 2018 Jun; 208(11):483-484. PubMed ID: 29902408 [No Abstract] [Full Text] [Related]
32. Measuring breast, colorectal, and prostate cancer screening with medicare claims data. Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166 [TBL] [Abstract][Full Text] [Related]
33. National Institutes of Health state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening. Steinwachs D; Allen JD; Barlow WE; Duncan RP; Egede LE; Friedman LS; Keating NL; Kim P; Lave JR; Laveist TA; Ness RB; Optican RJ; Virnig BA Ann Intern Med; 2010 May; 152(10):663-7. PubMed ID: 20388702 [No Abstract] [Full Text] [Related]
34. Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns? Kalyta A; De Vera MA; Peacock S; Telford JJ; Brown CJ; Donnellan F; Gill S; Loree JM Curr Oncol; 2021 Apr; 28(3):1558-1570. PubMed ID: 33919428 [TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer testing in Canada--2008. Wilkins K; Shields M Health Rep; 2009 Sep; 20(3):21-30. PubMed ID: 19813436 [TBL] [Abstract][Full Text] [Related]
36. Physician-patient communication regarding colorectal cancer screening is lacking. Barton MK CA Cancer J Clin; 2012; 62(1):1-2. PubMed ID: 22095204 [No Abstract] [Full Text] [Related]
37. Colorectal cancer screening patterns after the American Cancer Society's recommendation to initiate screening at age 45 years. Fedewa SA; Siegel RL; Goding Sauer A; Bandi P; Jemal A Cancer; 2020 Mar; 126(6):1351-1353. PubMed ID: 31850529 [No Abstract] [Full Text] [Related]
38. United States Preventive Services Task Force recommendations: age to end screening misunderstood. Zauber AG; van Ballegooijen M; Petitti D; Lansdorp-Vogelaar I Dis Colon Rectum; 2010 Oct; 53(10):1453; author reply 1453. PubMed ID: 20847630 [No Abstract] [Full Text] [Related]
39. From Colorectal Cancer Screening Guidelines to Headlines: Beware! Bretthauer M; Kalager M; Weinberg DS Ann Intern Med; 2018 Sep; 169(6):405-406. PubMed ID: 29987330 [No Abstract] [Full Text] [Related]
40. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective. Bond JH Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]